piR-hsa-211106 Inhibits the Progression of Lung Adenocarcinoma Through Pyruvate Carboxylase and Enhances Chemotherapy Sensitivity

Overview of attention for article published in Frontiers in oncology, June 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter: 2 X users

patent: 2 patents

Readers on

mendeley: 6 Mendeley

Summary X Patents

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 7,450 followers.

New article: piR-hsa-211106 Inhibits the Progression of Lung Adenocarcinoma Through Pyruvate Carboxylase and Enhances Chemotherapy Sensitivity https://t.co/x7lX07MYUp #lungcancer #oncology https://t.co/lVbI62O0AS

12 Jul 2021

Reply Repost Favourite

New research: piR-hsa-211106 Inhibits the Progression of Lung Adenocarcinoma Through Pyruvate Carboxylase and Enhances Chemotherapy Sensitivity: Although the importance of PIWI-interacting RNAs (piRNAs) in cancer has recently been recognized,… https://t.co

23 Jun 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.